UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1404) 1404
Magazine Article (12) 12
Book Chapter (4) 4
Conference Proceeding (2) 2
Newsletter (2) 2
Publication (2) 2
Book Review (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1137) 1137
ramipril - therapeutic use (1036) 1036
angiotensin-converting enzyme inhibitors - therapeutic use (893) 893
science & technology (848) 848
life sciences & biomedicine (839) 839
male (793) 793
female (635) 635
middle aged (546) 546
ramipril (468) 468
hypertension - drug therapy (443) 443
aged (410) 410
antihypertensive agents - therapeutic use (382) 382
cardiovascular system & cardiology (352) 352
blood pressure - drug effects (313) 313
adult (309) 309
treatment outcome (278) 278
animals (234) 234
abridged index medicus (225) 225
ramipril - pharmacology (219) 219
cardiac & cardiovascular systems (218) 218
drug therapy, combination (217) 217
hypertension (211) 211
risk factors (193) 193
double-blind method (191) 191
angiotensin-converting enzyme inhibitors - pharmacology (185) 185
pharmacology & pharmacy (184) 184
peripheral vascular disease (176) 176
ramipril - administration & dosage (176) 176
ramipril - adverse effects (155) 155
hypertension - physiopathology (152) 152
benzimidazoles - therapeutic use (151) 151
cardiovascular diseases - prevention & control (148) 148
general & internal medicine (142) 142
ace inhibitors (140) 140
medicine, general & internal (140) 140
angiotensin-converting enzyme inhibitors - adverse effects (138) 138
rats (135) 135
benzoates - therapeutic use (132) 132
randomized controlled trials as topic (130) 130
blood pressure (125) 125
angiotensin-converting enzyme inhibitors - administration & dosage (121) 121
prospective studies (121) 121
time factors (121) 121
follow-up studies (114) 114
angiotensin ii type 1 receptor blockers - therapeutic use (113) 113
drug therapy (107) 107
renin-angiotensin system - drug effects (100) 100
heart failure - drug therapy (99) 99
hypertension - complications (96) 96
diabetes (90) 90
cardiovascular diseases - drug therapy (88) 88
bridged bicyclo compounds - therapeutic use (85) 85
angiotensin-converting enzyme inhibitors (81) 81
enzymes (80) 80
research (80) 80
angiotensin (79) 79
urology & nephrology (78) 78
cardiovascular disease (77) 77
clinical trials as topic (77) 77
antihypertensive agents - administration & dosage (76) 76
myocardial infarction - drug therapy (74) 74
antihypertensive agents - pharmacology (73) 73
antihypertensive agents - adverse effects (70) 70
tetrazoles - therapeutic use (67) 67
heart failure (66) 66
telmisartan (66) 66
dose-response relationship, drug (65) 65
medicine & public health (65) 65
cardiovascular diseases (62) 62
disease progression (58) 58
heart rate - drug effects (58) 58
prevention (58) 58
aged, 80 and over (57) 57
prognosis (54) 54
care and treatment (52) 52
adolescent (51) 51
captopril - therapeutic use (51) 51
losartan - therapeutic use (51) 51
cardiology (50) 50
stroke - prevention & control (50) 50
bridged-ring compounds - therapeutic use (49) 49
diabetes mellitus, type 2 - drug therapy (49) 49
health aspects (49) 49
hemodynamics - drug effects (49) 49
myocardial infarction - prevention & control (49) 49
proteinuria (49) 49
amlodipine - therapeutic use (48) 48
diabetes mellitus, type 2 - complications (48) 48
internal medicine (48) 48
adrenergic beta-antagonists - therapeutic use (47) 47
clinical trials (46) 46
dosage and administration (46) 46
endocrinology & metabolism (46) 46
mortality (46) 46
disease models, animal (44) 44
echocardiography (44) 44
proteinuria - drug therapy (44) 44
rats, inbred shr (44) 44
retrospective studies (44) 44
calcium channel blockers - therapeutic use (43) 43
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1283) 1283
German (61) 61
Russian (32) 32
French (25) 25
Spanish (15) 15
Italian (12) 12
Hungarian (7) 7
Chinese (6) 6
Japanese (5) 5
Croatian (3) 3
Ukrainian (3) 3
Lithuanian (2) 2
Czech (1) 1
Dutch (1) 1
Finnish (1) 1
Hebrew (1) 1
Polish (1) 1
Portuguese (1) 1
Serbian (1) 1
Swedish (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Hypertension (Dallas, Tex. 1979), ISSN 0194-911X, 02/2007, Volume 49, Issue 2, pp. 276 - 284
Thiazide diuretics, angiotensin-converting enzyme inhibitors, and angiotensin receptor blockers all cause reactive rises in plasma renin activity. We... 
Hypertension | Aliskiren | Renin inhibitor | Renin-angiotensin-aldosterone system | Combination therapy | Plasma renin activity | Ambulatory blood pressure measurement | Peripheral Vascular Disease | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Angiotensin II Type 1 Receptor Blockers - adverse effects | Angiotensin II Type 1 Receptor Blockers - therapeutic use | Humans | Middle Aged | Biphenyl Compounds - adverse effects | Amides | Hypertension - drug therapy | Male | Sodium Chloride Symporter Inhibitors - adverse effects | Sodium Chloride Symporter Inhibitors - therapeutic use | Biphenyl Compounds - therapeutic use | Hypertension - blood | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Angiotensin-Converting Enzyme Inhibitors - adverse effects | Aged, 80 and over | Adult | Female | Blood Pressure - drug effects | Ramipril - therapeutic use | Drug Therapy, Combination | Hypertension - diagnosis | Ramipril - adverse effects | Hydrochlorothiazide - adverse effects | Fumarates - therapeutic use | Fumarates - adverse effects | Antihypertensive Agents - therapeutic use | Renin - blood | Hypertension - physiopathology | Antihypertensive Agents - adverse effects | Antihypertensive Agents - blood | Fumarates - blood | Renin - antagonists & inhibitors | Tetrazoles - therapeutic use | Aged | Patient Compliance | Tetrazoles - adverse effects | Blood Pressure Monitoring, Ambulatory | Hydrochlorothiazide - therapeutic use | Index Medicus
Journal Article
The New England journal of medicine, ISSN 1533-4406, 09/2008, Volume 359, Issue 12, pp. 1225 - 1237
In a multicenter trial, 20,332 patients who had recently had an ischemic stroke were randomly assigned to receive either telmisartan or placebo. All patients... 
MORTALITY | HIGH-RISK PATIENTS | DESIGN | RAMIPRIL | RATIONALE | DOUBLE-BLIND | VASCULAR EVENTS | COMBINATION | UMCG Approved | BLOOD-PRESSURE | RANDOMIZED TRIAL | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Benzoates - adverse effects | Myocardial Infarction - epidemiology | Benzoates - therapeutic use | Follow-Up Studies | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Male | Secondary Prevention | Heart Failure - prevention & control | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Treatment Failure | Angiotensin-Converting Enzyme Inhibitors - adverse effects | Cardiovascular Diseases - epidemiology | Cardiovascular Diseases - mortality | Female | Blood Pressure - drug effects | Benzimidazoles - adverse effects | Heart Failure - epidemiology | Benzimidazoles - therapeutic use | Stroke - prevention & control | Kaplan-Meier Estimate | Stroke - drug therapy | Diabetes Mellitus - epidemiology | Creatinine - blood | Potassium - blood | Aged | Myocardial Infarction - prevention & control | Stroke (Disease) | Prevention | Usage | Health aspects | Telmisartan | Medical research | Stroke | Blood pressure | Index Medicus | Abridged Index Medicus | Blood Pressure | Creatinine | Recurrence | Benzimidazoles | Cardiovascular Diseases | Benzoates | Diabetes Mellitus | Geriatry and gerontology | Life Sciences | Human health and pathology | Myocardial Infarction | Angiotensin-Converting Enzyme Inhibitors | Heart Failure | Potassium | Cardiology and cardiovascular system | Original | Benzimidazoles/adverse effects/therapeutic use | Diabetes Mellitus/epidemiology | Angiotensin-Converting Enzyme Inhibitors/adverse effects/therapeutic use | Recurrence/prevention & control | Stroke/drug therapy/prevention & control | MEDICIN OCH HÄLSOVETENSKAP | Creatinine/blood | Potassium/blood | Blood Pressure/drug effects | Cardiovascular Diseases/epidemiology/mortality/prevention & control | Benzoates/adverse effects/therapeutic use | Myocardial Infarction/epidemiology/prevention & control | Kaplan-Meiers Estimate | MEDICAL AND HEALTH SCIENCES | Heart Failure/epidemiology/prevention & control
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2008, Volume 372, Issue 9638, pp. 547 - 553
Journal Article
JAMA : the journal of the American Medical Association, ISSN 0098-7484, 06/2001, Volume 285, Issue 21, pp. 2719 - 2728
Journal Article
by Yusuf, S and Haridas, K. K and Iyengar, S. S and Jaison, T. M and Joshi, P and Kerkar, P and Naik, S and Prabhakaran, D and Thanikachalam, S and Thomas, N and Parwani, J and Maseeh, A and Srinivasulu, B and Srinivas, J and Rangadham, K and Rayadurgee, N. M and Balaji, Y and Bhavishya, Y and Parikh, K and Chag, M and Shah, U and Joseph, J. J. J and Nesaraj, K. J and Malarvizhi, V and Patil, C. B and Bantwal, G and Nagesh, H and Santosh, M. I and Dwivedi, S and Ramesh, S. S and Suresh, S and Ayyar, V and Rana, P and Tumari, D. P and Agarwal, N. B and Deshpande, N and Bhagchandani, R and Bhagchandani, S and Gupta, B. K and Agarwal, D. K and Panwar, R. B and Bindu, A. V and Alexander, K. G and Pradeep, R and Nambiar, A and Das, C. K and Ramu, M and Nayar, P and Poongothai, S and Mohan, V and Chidambaram, N and Diwan, R and Umarani, R and Bhuvaneswaran, J. S and Mehta, A and Mittal, A and Sahwnay, J. P. S and Sidhu, G and Mehta, R and Singh, R and Bhambari, S and Rain, A. R and Sastry, B. K. S and Rao, D and Karmalkar, M and Shah, P. K and Govindaiah, P and Dharmi, S and Joshi, S and Naik, S and Gulla, S. P and Rao, S. P and Bharani, A and Patel, A and Mishra, B. S and Chandwani, P and Gupta, R and Sreenivas, N and Reddy, S. V. R and Reddy, T. V. K and Kumar, V and Roy, D. G and Paul, S. K and Puri, A and Fisher, L and Sinha, N and Saxena, P and Kumar, S and Puri, V. K and Modi, A and Thacker, H. P and Mehta, K and Mehta, P and Srinivas, A and Guruprasad, H. P and Bawangade, A and Khan, A and Jain, A. S and Sane, D and Deshpande, M and ... and The Indian Polycap Study (TIPS) and Indian Polycap Study (TIPS)
The Lancet (British edition), ISSN 0140-6736, 2009, Volume 373, Issue 9672, pp. 1341 - 1351
Journal Article
Clinical science (1979), ISSN 1470-8736, 08/2012, Volume 123, Issue 11, pp. 649 - 658
The RAS (renin–angiotensin system) is activated after MI (myocardial infarction), and RAS blockade with ACEis [ACE (angiotensin-converting enzyme) inhibitors]... 
Myocardial infarction | Angiotensin-converting enzyme inhibitor | Angiotensin receptor blocker | Angiotensin-converting enzyme | Renin-angiotensin system | Life Sciences & Biomedicine | Medicine, Research & Experimental | Science & Technology | Research & Experimental Medicine | Immunohistochemistry | Gene Expression Regulation, Enzymologic - drug effects | Myocardial Infarction - genetics | Tetrazoles - pharmacology | Valsartan | Angiotensin II Type 1 Receptor Blockers - therapeutic use | Angiotensin II Type 1 Receptor Blockers - pharmacology | Peptidyl-Dipeptidase A - genetics | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Peptidyl-Dipeptidase A - blood | Myocardium - metabolism | Peptidyl-Dipeptidase A - metabolism | Female | Angiotensin-Converting Enzyme Inhibitors - pharmacology | Ramipril - pharmacology | Ramipril - therapeutic use | Drug Therapy, Combination | Heart - physiopathology | Angiotensins - blood | Valine - analogs & derivatives | Rats | Myocardium - pathology | Myocardial Infarction - metabolism | Renin - blood | Reverse Transcriptase Polymerase Chain Reaction | Rats, Sprague-Dawley | Organ Size - drug effects | Animals | Myocardial Infarction - drug therapy | Heart - drug effects | Renin-Angiotensin System - drug effects | Tetrazoles - therapeutic use | Valine - therapeutic use | Hemodynamics - drug effects | Valine - pharmacology | Index Medicus
Journal Article
European journal of heart failure, ISSN 1388-9842, 08/2005, Volume 7, Issue 5, pp. 710 - 721
...‐being and prolong life. This may be due to unfamiliarity with the evidence‐base for these therapies, the clinical guidelines recommending the use of these treatments or both, as well as concerns regarding adverse events... 
Heart failure | Isosorbide dinitrate | Beta‐blockers | Digoxin | Angiotensin receptor blockers | Pharmacology | Aldosterone antagonists | Treatment | Eplerenone | Spironolactone | Hydralazine | ACE inhibitors | Clinical recommendations | Beta-blockers | Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Benzopyrans - therapeutic use | Valsartan | Angiotensin Receptor Antagonists | Bisoprolol - therapeutic use | Humans | Carbazoles - administration & dosage | Heart Failure - physiopathology | Valine - administration & dosage | Enalapril - therapeutic use | Ethanolamines - administration & dosage | Indoles - administration & dosage | Ramipril - administration & dosage | Captopril - therapeutic use | Propanolamines - therapeutic use | Lisinopril - therapeutic use | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Benzimidazoles - administration & dosage | Tetrazoles - administration & dosage | Ramipril - therapeutic use | Drug Therapy, Combination | Enalapril - administration & dosage | Spironolactone - therapeutic use | Adrenergic beta-Antagonists - administration & dosage | Adrenergic beta-Antagonists - therapeutic use | Benzimidazoles - therapeutic use | Lisinopril - administration & dosage | Nebivolol | Valine - analogs & derivatives | Metoprolol - therapeutic use | Metoprolol - administration & dosage | Evidence-Based Medicine | Angiotensin-Converting Enzyme Inhibitors - administration & dosage | Bisoprolol - administration & dosage | Heart Failure - drug therapy | Mineralocorticoid Receptor Antagonists - therapeutic use | Stroke Volume | Benzopyrans - administration & dosage | Captopril - administration & dosage | Guideline Adherence | Ethanolamines - therapeutic use | Indoles - therapeutic use | Metoprolol - analogs & derivatives | Tetrazoles - therapeutic use | Valine - therapeutic use | Carbazoles - therapeutic use | Propanolamines - administration & dosage | Practice Guidelines as Topic | Prescription writing | Corticosteroids | Isosorbide mononitrate | Family medicine | Nitrates | Peptide hormones | Aldosterone | Preventive health services | Cardiac patients | Angiotensin | Antiandrogens | Medicine, Preventive | Steroids | Index Medicus | Kardiologi | converting-enzyme-inhibitors | Cardiac and Cardiovascular Systems | randomized intervention trial | quality-of-care | elderly-patients | isosorbide dinitrate | cardiac-insufficiency | national-survey | medical-treatment | ventricular systolic dysfunction | general-practice
Journal Article